BrainSightAI
BrainSightAI enables greater precision in the diagnosis and prognosis of neurological and psychiatric disorders, using AI and digital phenotypes.
Neuro-psychiatric disorders are the leading cause of disability worldwide. Clinicians today do not have access to cutting-edge tools for early diagnosis and individualized modeling. This severely limits the efficacy of treatments and therapies for patients, and increases the risk associated with clinical trials.
BrainSightAI empowers clinicians to build the most bio-realistic virtual twin of a person’s brain, based on just a functional MRI scan. AI powered computational neuroscience analysis on this virtual twin then helps diagnose the disease earlier, more effectively plan brain surgeries, and craft personalized brain interventions. This, combined with the digital phenotyping app launched by BrainSight, gives an unprecedented view of the patient and their disease.
Founders
Laina Emmanuel
CEO
Laina has over 15 years of experience in healthcare management, policy and consulting. She has an MBA in Marketing and Healthcare from the Indian School of Business, and experience consulting for the Government of India and organizations such as Clinton Health Access Initiative.
Dr. Rimjhim Agrawal
CTO
Rimjhim holds a PhD in Machine Learning in Psychiatry from the National Institute of Mental Health and Neuro Sciences of Bengaluru. She has over 5 years of experience in this field, and has published 10+ papers on topics such as computational psychiatry, machine learning algorithms for the analysis, classification and regression of neuroimaging (structural, functional MRI, and DTI), and dermatoglyphics.
Milestones
Founded at Entrepreneur First
Seed ($750,000) led by Stanford Angels